nodes	percent_of_prediction	percent_of_DWPC	metapath
Idarubicin—Epirubicin—testicular cancer	0.15	0.519	CrCtD
Idarubicin—Doxorubicin—testicular cancer	0.138	0.481	CrCtD
Idarubicin—Anthracyclines—Epirubicin—testicular cancer	0.1	0.271	CiPCiCtD
Idarubicin—Anthracyclines—Doxorubicin—testicular cancer	0.0926	0.251	CiPCiCtD
Idarubicin—Topoisomerase Inhibitors—Etoposide—testicular cancer	0.076	0.206	CiPCiCtD
Idarubicin—Topoisomerase Inhibitors—Epirubicin—testicular cancer	0.0523	0.142	CiPCiCtD
Idarubicin—Topoisomerase Inhibitors—Doxorubicin—testicular cancer	0.0484	0.131	CiPCiCtD
Idarubicin—Daunorubicin—Epirubicin—testicular cancer	0.0319	0.173	CrCrCtD
Idarubicin—Doxorubicin—Epirubicin—testicular cancer	0.0319	0.173	CrCrCtD
Idarubicin—Valrubicin—Epirubicin—testicular cancer	0.0319	0.173	CrCrCtD
Idarubicin—Daunorubicin—Doxorubicin—testicular cancer	0.0295	0.16	CrCrCtD
Idarubicin—Valrubicin—Doxorubicin—testicular cancer	0.0295	0.16	CrCrCtD
Idarubicin—Epirubicin—Doxorubicin—testicular cancer	0.0295	0.16	CrCrCtD
Idarubicin—TOP2A—Epirubicin—testicular cancer	0.0211	0.178	CbGbCtD
Idarubicin—TOP2A—Etoposide—testicular cancer	0.0164	0.138	CbGbCtD
Idarubicin—ABCC1—Dactinomycin—testicular cancer	0.0161	0.136	CbGbCtD
Idarubicin—ABCC1—Epirubicin—testicular cancer	0.0117	0.0985	CbGbCtD
Idarubicin—TOP2A—Doxorubicin—testicular cancer	0.0112	0.0944	CbGbCtD
Idarubicin—ABCC1—Vinblastine—testicular cancer	0.0101	0.0852	CbGbCtD
Idarubicin—ABCC1—Etoposide—testicular cancer	0.00911	0.0767	CbGbCtD
Idarubicin—ABCC1—Doxorubicin—testicular cancer	0.00621	0.0523	CbGbCtD
Idarubicin—ABCC1—Methotrexate—testicular cancer	0.00602	0.0507	CbGbCtD
Idarubicin—CYP2C9—Ifosfamide—testicular cancer	0.00474	0.0399	CbGbCtD
Idarubicin—CYP2C9—Cisplatin—testicular cancer	0.0023	0.0194	CbGbCtD
Idarubicin—CYP2D6—Vinblastine—testicular cancer	0.0023	0.0194	CbGbCtD
Idarubicin—CYP2D6—Doxorubicin—testicular cancer	0.00141	0.0119	CbGbCtD
Idarubicin—TOP2A—Vindesine—Vinblastine—testicular cancer	0.000154	0.213	CbGdCrCtD
Idarubicin—TOP2A—Vinorelbine—Vinblastine—testicular cancer	9.72e-05	0.134	CbGdCrCtD
Idarubicin—TOP2A—Teniposide—Etoposide—testicular cancer	9.71e-05	0.134	CbGdCrCtD
Idarubicin—TOP2A—Podofilox—Etoposide—testicular cancer	9.71e-05	0.134	CbGdCrCtD
Idarubicin—TOP2A—Vincristine—Vinblastine—testicular cancer	8.31e-05	0.115	CbGdCrCtD
Idarubicin—TOP2A—Doxorubicin—Epirubicin—testicular cancer	5.07e-05	0.07	CbGdCrCtD
Idarubicin—TOP2A—Daunorubicin—Epirubicin—testicular cancer	5.07e-05	0.07	CbGdCrCtD
Idarubicin—TOP2A—Epirubicin—Doxorubicin—testicular cancer	4.69e-05	0.0648	CbGdCrCtD
Idarubicin—TOP2A—Daunorubicin—Doxorubicin—testicular cancer	4.69e-05	0.0648	CbGdCrCtD
Idarubicin—Stomatitis—Etoposide—testicular cancer	3.98e-05	0.00103	CcSEcCtD
Idarubicin—Decreased appetite—Vinblastine—testicular cancer	3.97e-05	0.00103	CcSEcCtD
Idarubicin—Urticaria—Chlorambucil—testicular cancer	3.96e-05	0.00102	CcSEcCtD
Idarubicin—Neoplasm—Methotrexate—testicular cancer	3.95e-05	0.00102	CcSEcCtD
Idarubicin—Urinary tract disorder—Cisplatin—testicular cancer	3.95e-05	0.00102	CcSEcCtD
Idarubicin—Leukopenia—Dactinomycin—testicular cancer	3.94e-05	0.00102	CcSEcCtD
Idarubicin—Abdominal pain—Chlorambucil—testicular cancer	3.94e-05	0.00102	CcSEcCtD
Idarubicin—Body temperature increased—Chlorambucil—testicular cancer	3.94e-05	0.00102	CcSEcCtD
Idarubicin—Colitis—Epirubicin—testicular cancer	3.92e-05	0.00102	CcSEcCtD
Idarubicin—Urethral disorder—Cisplatin—testicular cancer	3.92e-05	0.00101	CcSEcCtD
Idarubicin—Atrioventricular block—Doxorubicin—testicular cancer	3.9e-05	0.00101	CcSEcCtD
Idarubicin—Anaphylactic shock—Bleomycin—testicular cancer	3.85e-05	0.000997	CcSEcCtD
Idarubicin—Blood uric acid increased—Doxorubicin—testicular cancer	3.85e-05	0.000996	CcSEcCtD
Idarubicin—Infection—Bleomycin—testicular cancer	3.83e-05	0.000991	CcSEcCtD
Idarubicin—Sepsis—Methotrexate—testicular cancer	3.79e-05	0.000981	CcSEcCtD
Idarubicin—Thrombocytopenia—Bleomycin—testicular cancer	3.77e-05	0.000976	CcSEcCtD
Idarubicin—Oesophagitis—Epirubicin—testicular cancer	3.73e-05	0.000966	CcSEcCtD
Idarubicin—Gastrointestinal pain—Vinblastine—testicular cancer	3.73e-05	0.000965	CcSEcCtD
Idarubicin—Anaemia—Ifosfamide—testicular cancer	3.73e-05	0.000965	CcSEcCtD
Idarubicin—Flushing—Cisplatin—testicular cancer	3.71e-05	0.00096	CcSEcCtD
Idarubicin—Neoplasm—Epirubicin—testicular cancer	3.69e-05	0.000956	CcSEcCtD
Idarubicin—Anorexia—Bleomycin—testicular cancer	3.67e-05	0.00095	CcSEcCtD
Idarubicin—Hypersensitivity—Chlorambucil—testicular cancer	3.67e-05	0.000949	CcSEcCtD
Idarubicin—Thrombophlebitis—Methotrexate—testicular cancer	3.66e-05	0.000948	CcSEcCtD
Idarubicin—Colitis—Doxorubicin—testicular cancer	3.63e-05	0.000939	CcSEcCtD
Idarubicin—Urinary tract disorder—Etoposide—testicular cancer	3.62e-05	0.000936	CcSEcCtD
Idarubicin—Leukopenia—Ifosfamide—testicular cancer	3.61e-05	0.000935	CcSEcCtD
Idarubicin—Immune system disorder—Cisplatin—testicular cancer	3.61e-05	0.000934	CcSEcCtD
Idarubicin—Abdominal pain—Vinblastine—testicular cancer	3.61e-05	0.000933	CcSEcCtD
Idarubicin—Urethral disorder—Etoposide—testicular cancer	3.59e-05	0.000929	CcSEcCtD
Idarubicin—Infection—Dactinomycin—testicular cancer	3.57e-05	0.000924	CcSEcCtD
Idarubicin—Arrhythmia—Cisplatin—testicular cancer	3.57e-05	0.000924	CcSEcCtD
Idarubicin—Sepsis—Epirubicin—testicular cancer	3.55e-05	0.000918	CcSEcCtD
Idarubicin—Alopecia—Cisplatin—testicular cancer	3.53e-05	0.000914	CcSEcCtD
Idarubicin—Thrombocytopenia—Dactinomycin—testicular cancer	3.52e-05	0.00091	CcSEcCtD
Idarubicin—Convulsion—Ifosfamide—testicular cancer	3.5e-05	0.000905	CcSEcCtD
Idarubicin—Malnutrition—Cisplatin—testicular cancer	3.48e-05	0.0009	CcSEcCtD
Idarubicin—Oesophagitis—Doxorubicin—testicular cancer	3.46e-05	0.000894	CcSEcCtD
Idarubicin—Phlebitis—Epirubicin—testicular cancer	3.44e-05	0.000891	CcSEcCtD
Idarubicin—Chest pain—Ifosfamide—testicular cancer	3.44e-05	0.000889	CcSEcCtD
Idarubicin—Thrombophlebitis—Epirubicin—testicular cancer	3.43e-05	0.000887	CcSEcCtD
Idarubicin—Anorexia—Dactinomycin—testicular cancer	3.43e-05	0.000886	CcSEcCtD
Idarubicin—Neoplasm—Doxorubicin—testicular cancer	3.42e-05	0.000885	CcSEcCtD
Idarubicin—Unspecified disorder of skin and subcutaneous tissue—Ifosfamide—testicular cancer	3.41e-05	0.000883	CcSEcCtD
Idarubicin—Diarrhoea—Chlorambucil—testicular cancer	3.41e-05	0.000881	CcSEcCtD
Idarubicin—Flushing—Etoposide—testicular cancer	3.4e-05	0.000879	CcSEcCtD
Idarubicin—Hepatic function abnormal—Epirubicin—testicular cancer	3.39e-05	0.000878	CcSEcCtD
Idarubicin—Hypersensitivity—Vinblastine—testicular cancer	3.36e-05	0.00087	CcSEcCtD
Idarubicin—Decreased appetite—Bleomycin—testicular cancer	3.35e-05	0.000867	CcSEcCtD
Idarubicin—Angiopathy—Etoposide—testicular cancer	3.32e-05	0.000859	CcSEcCtD
Idarubicin—Immune system disorder—Etoposide—testicular cancer	3.31e-05	0.000856	CcSEcCtD
Idarubicin—Anaphylactic shock—Ifosfamide—testicular cancer	3.29e-05	0.000852	CcSEcCtD
Idarubicin—Chills—Etoposide—testicular cancer	3.28e-05	0.00085	CcSEcCtD
Idarubicin—Sepsis—Doxorubicin—testicular cancer	3.28e-05	0.000849	CcSEcCtD
Idarubicin—Infection—Ifosfamide—testicular cancer	3.27e-05	0.000847	CcSEcCtD
Idarubicin—Cardiac failure congestive—Epirubicin—testicular cancer	3.27e-05	0.000846	CcSEcCtD
Idarubicin—Alopecia—Etoposide—testicular cancer	3.24e-05	0.000837	CcSEcCtD
Idarubicin—Thrombocytopenia—Ifosfamide—testicular cancer	3.22e-05	0.000834	CcSEcCtD
Idarubicin—Anaemia—Cisplatin—testicular cancer	3.22e-05	0.000832	CcSEcCtD
Idarubicin—Skin disorder—Ifosfamide—testicular cancer	3.2e-05	0.000828	CcSEcCtD
Idarubicin—Phlebitis—Doxorubicin—testicular cancer	3.19e-05	0.000824	CcSEcCtD
Idarubicin—Hot flush—Epirubicin—testicular cancer	3.17e-05	0.000821	CcSEcCtD
Idarubicin—Thrombophlebitis—Doxorubicin—testicular cancer	3.17e-05	0.00082	CcSEcCtD
Idarubicin—Vomiting—Chlorambucil—testicular cancer	3.17e-05	0.000819	CcSEcCtD
Idarubicin—Menopausal symptoms—Epirubicin—testicular cancer	3.14e-05	0.000813	CcSEcCtD
Idarubicin—Hepatic function abnormal—Doxorubicin—testicular cancer	3.14e-05	0.000813	CcSEcCtD
Idarubicin—Anorexia—Ifosfamide—testicular cancer	3.14e-05	0.000812	CcSEcCtD
Idarubicin—Decreased appetite—Dactinomycin—testicular cancer	3.12e-05	0.000808	CcSEcCtD
Idarubicin—Diarrhoea—Vinblastine—testicular cancer	3.12e-05	0.000808	CcSEcCtD
Idarubicin—Leukopenia—Cisplatin—testicular cancer	3.11e-05	0.000806	CcSEcCtD
Idarubicin—Urticaria—Bleomycin—testicular cancer	3.06e-05	0.000792	CcSEcCtD
Idarubicin—Body temperature increased—Bleomycin—testicular cancer	3.05e-05	0.000788	CcSEcCtD
Idarubicin—Cardiac failure congestive—Doxorubicin—testicular cancer	3.03e-05	0.000783	CcSEcCtD
Idarubicin—Convulsion—Cisplatin—testicular cancer	3.01e-05	0.00078	CcSEcCtD
Idarubicin—Nausea—Chlorambucil—testicular cancer	2.96e-05	0.000765	CcSEcCtD
Idarubicin—Anaemia—Etoposide—testicular cancer	2.95e-05	0.000762	CcSEcCtD
Idarubicin—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—testicular cancer	2.94e-05	0.000761	CcSEcCtD
Idarubicin—Gastrointestinal pain—Dactinomycin—testicular cancer	2.94e-05	0.00076	CcSEcCtD
Idarubicin—Hot flush—Doxorubicin—testicular cancer	2.93e-05	0.000759	CcSEcCtD
Idarubicin—Menopausal symptoms—Doxorubicin—testicular cancer	2.91e-05	0.000753	CcSEcCtD
Idarubicin—Vomiting—Vinblastine—testicular cancer	2.9e-05	0.000751	CcSEcCtD
Idarubicin—Decreased appetite—Ifosfamide—testicular cancer	2.86e-05	0.000741	CcSEcCtD
Idarubicin—Headache—Vinblastine—testicular cancer	2.86e-05	0.00074	CcSEcCtD
Idarubicin—Leukopenia—Etoposide—testicular cancer	2.85e-05	0.000738	CcSEcCtD
Idarubicin—Body temperature increased—Dactinomycin—testicular cancer	2.84e-05	0.000735	CcSEcCtD
Idarubicin—Abdominal pain—Dactinomycin—testicular cancer	2.84e-05	0.000735	CcSEcCtD
Idarubicin—Anaphylactic shock—Cisplatin—testicular cancer	2.84e-05	0.000735	CcSEcCtD
Idarubicin—Hypersensitivity—Bleomycin—testicular cancer	2.84e-05	0.000735	CcSEcCtD
Idarubicin—Infection—Cisplatin—testicular cancer	2.82e-05	0.00073	CcSEcCtD
Idarubicin—Thrombocytopenia—Cisplatin—testicular cancer	2.78e-05	0.000719	CcSEcCtD
Idarubicin—Convulsion—Etoposide—testicular cancer	2.76e-05	0.000715	CcSEcCtD
Idarubicin—Dehydration—Epirubicin—testicular cancer	2.76e-05	0.000714	CcSEcCtD
Idarubicin—Skin disorder—Cisplatin—testicular cancer	2.76e-05	0.000714	CcSEcCtD
Idarubicin—Chest pain—Etoposide—testicular cancer	2.71e-05	0.000702	CcSEcCtD
Idarubicin—Nausea—Vinblastine—testicular cancer	2.71e-05	0.000701	CcSEcCtD
Idarubicin—Anorexia—Cisplatin—testicular cancer	2.71e-05	0.0007	CcSEcCtD
Idarubicin—Unspecified disorder of skin and subcutaneous tissue—Etoposide—testicular cancer	2.69e-05	0.000697	CcSEcCtD
Idarubicin—Gastrointestinal pain—Ifosfamide—testicular cancer	2.69e-05	0.000697	CcSEcCtD
Idarubicin—Hypersensitivity—Dactinomycin—testicular cancer	2.65e-05	0.000685	CcSEcCtD
Idarubicin—Urticaria—Ifosfamide—testicular cancer	2.62e-05	0.000677	CcSEcCtD
Idarubicin—Abdominal pain—Ifosfamide—testicular cancer	2.6e-05	0.000674	CcSEcCtD
Idarubicin—Body temperature increased—Ifosfamide—testicular cancer	2.6e-05	0.000674	CcSEcCtD
Idarubicin—Pancytopenia—Methotrexate—testicular cancer	2.6e-05	0.000673	CcSEcCtD
Idarubicin—Anaphylactic shock—Etoposide—testicular cancer	2.6e-05	0.000673	CcSEcCtD
Idarubicin—Infection—Etoposide—testicular cancer	2.58e-05	0.000669	CcSEcCtD
Idarubicin—Neutropenia—Methotrexate—testicular cancer	2.56e-05	0.000663	CcSEcCtD
Idarubicin—Dehydration—Doxorubicin—testicular cancer	2.55e-05	0.000661	CcSEcCtD
Idarubicin—Thrombocytopenia—Etoposide—testicular cancer	2.55e-05	0.000659	CcSEcCtD
Idarubicin—Skin disorder—Etoposide—testicular cancer	2.53e-05	0.000654	CcSEcCtD
Idarubicin—Anorexia—Etoposide—testicular cancer	2.48e-05	0.000642	CcSEcCtD
Idarubicin—Decreased appetite—Cisplatin—testicular cancer	2.47e-05	0.000639	CcSEcCtD
Idarubicin—Diarrhoea—Dactinomycin—testicular cancer	2.46e-05	0.000636	CcSEcCtD
Idarubicin—Vomiting—Bleomycin—testicular cancer	2.45e-05	0.000634	CcSEcCtD
Idarubicin—Pancytopenia—Epirubicin—testicular cancer	2.43e-05	0.00063	CcSEcCtD
Idarubicin—Rash—Bleomycin—testicular cancer	2.43e-05	0.000629	CcSEcCtD
Idarubicin—Dermatitis—Bleomycin—testicular cancer	2.43e-05	0.000628	CcSEcCtD
Idarubicin—Hypersensitivity—Ifosfamide—testicular cancer	2.43e-05	0.000628	CcSEcCtD
Idarubicin—Neutropenia—Epirubicin—testicular cancer	2.4e-05	0.00062	CcSEcCtD
Idarubicin—Stomatitis—Methotrexate—testicular cancer	2.38e-05	0.000616	CcSEcCtD
Idarubicin—Nausea—Bleomycin—testicular cancer	2.29e-05	0.000592	CcSEcCtD
Idarubicin—Vomiting—Dactinomycin—testicular cancer	2.28e-05	0.000591	CcSEcCtD
Idarubicin—Rash—Dactinomycin—testicular cancer	2.27e-05	0.000586	CcSEcCtD
Idarubicin—Decreased appetite—Etoposide—testicular cancer	2.26e-05	0.000585	CcSEcCtD
Idarubicin—Diarrhoea—Ifosfamide—testicular cancer	2.25e-05	0.000583	CcSEcCtD
Idarubicin—Pancytopenia—Doxorubicin—testicular cancer	2.25e-05	0.000583	CcSEcCtD
Idarubicin—Body temperature increased—Cisplatin—testicular cancer	2.24e-05	0.000581	CcSEcCtD
Idarubicin—Stomatitis—Epirubicin—testicular cancer	2.23e-05	0.000577	CcSEcCtD
Idarubicin—Neutropenia—Doxorubicin—testicular cancer	2.22e-05	0.000574	CcSEcCtD
Idarubicin—Haemoglobin—Methotrexate—testicular cancer	2.2e-05	0.00057	CcSEcCtD
Idarubicin—Haemorrhage—Methotrexate—testicular cancer	2.19e-05	0.000567	CcSEcCtD
Idarubicin—Urinary tract disorder—Methotrexate—testicular cancer	2.17e-05	0.00056	CcSEcCtD
Idarubicin—Urethral disorder—Methotrexate—testicular cancer	2.15e-05	0.000556	CcSEcCtD
Idarubicin—Nausea—Dactinomycin—testicular cancer	2.13e-05	0.000552	CcSEcCtD
Idarubicin—Gastrointestinal pain—Etoposide—testicular cancer	2.13e-05	0.00055	CcSEcCtD
Idarubicin—Vomiting—Ifosfamide—testicular cancer	2.09e-05	0.000542	CcSEcCtD
Idarubicin—Hypersensitivity—Cisplatin—testicular cancer	2.09e-05	0.000541	CcSEcCtD
Idarubicin—Rash—Ifosfamide—testicular cancer	2.08e-05	0.000537	CcSEcCtD
Idarubicin—Dermatitis—Ifosfamide—testicular cancer	2.07e-05	0.000537	CcSEcCtD
Idarubicin—Urticaria—Etoposide—testicular cancer	2.07e-05	0.000535	CcSEcCtD
Idarubicin—Haemoglobin—Epirubicin—testicular cancer	2.06e-05	0.000534	CcSEcCtD
Idarubicin—Stomatitis—Doxorubicin—testicular cancer	2.06e-05	0.000534	CcSEcCtD
Idarubicin—Abdominal pain—Etoposide—testicular cancer	2.06e-05	0.000532	CcSEcCtD
Idarubicin—Body temperature increased—Etoposide—testicular cancer	2.06e-05	0.000532	CcSEcCtD
Idarubicin—Haemorrhage—Epirubicin—testicular cancer	2.05e-05	0.000531	CcSEcCtD
Idarubicin—Urinary tract disorder—Epirubicin—testicular cancer	2.03e-05	0.000524	CcSEcCtD
Idarubicin—Urethral disorder—Epirubicin—testicular cancer	2.01e-05	0.000521	CcSEcCtD
Idarubicin—Angiopathy—Methotrexate—testicular cancer	1.99e-05	0.000515	CcSEcCtD
Idarubicin—Immune system disorder—Methotrexate—testicular cancer	1.98e-05	0.000513	CcSEcCtD
Idarubicin—Chills—Methotrexate—testicular cancer	1.97e-05	0.000509	CcSEcCtD
Idarubicin—Nausea—Ifosfamide—testicular cancer	1.96e-05	0.000506	CcSEcCtD
Idarubicin—Diarrhoea—Cisplatin—testicular cancer	1.94e-05	0.000503	CcSEcCtD
Idarubicin—Alopecia—Methotrexate—testicular cancer	1.94e-05	0.000501	CcSEcCtD
Idarubicin—Hypersensitivity—Etoposide—testicular cancer	1.92e-05	0.000496	CcSEcCtD
Idarubicin—Malnutrition—Methotrexate—testicular cancer	1.91e-05	0.000494	CcSEcCtD
Idarubicin—Haemoglobin—Doxorubicin—testicular cancer	1.91e-05	0.000494	CcSEcCtD
Idarubicin—Flushing—Epirubicin—testicular cancer	1.9e-05	0.000493	CcSEcCtD
Idarubicin—Haemorrhage—Doxorubicin—testicular cancer	1.9e-05	0.000491	CcSEcCtD
Idarubicin—Urinary tract disorder—Doxorubicin—testicular cancer	1.88e-05	0.000485	CcSEcCtD
Idarubicin—Angiopathy—Epirubicin—testicular cancer	1.86e-05	0.000482	CcSEcCtD
Idarubicin—Urethral disorder—Doxorubicin—testicular cancer	1.86e-05	0.000482	CcSEcCtD
Idarubicin—Immune system disorder—Epirubicin—testicular cancer	1.85e-05	0.00048	CcSEcCtD
Idarubicin—Chills—Epirubicin—testicular cancer	1.84e-05	0.000476	CcSEcCtD
Idarubicin—Arrhythmia—Epirubicin—testicular cancer	1.83e-05	0.000474	CcSEcCtD
Idarubicin—Alopecia—Epirubicin—testicular cancer	1.81e-05	0.000469	CcSEcCtD
Idarubicin—Vomiting—Cisplatin—testicular cancer	1.81e-05	0.000467	CcSEcCtD
Idarubicin—Rash—Cisplatin—testicular cancer	1.79e-05	0.000463	CcSEcCtD
Idarubicin—Dermatitis—Cisplatin—testicular cancer	1.79e-05	0.000463	CcSEcCtD
Idarubicin—Malnutrition—Epirubicin—testicular cancer	1.79e-05	0.000462	CcSEcCtD
Idarubicin—Diarrhoea—Etoposide—testicular cancer	1.78e-05	0.00046	CcSEcCtD
Idarubicin—Anaemia—Methotrexate—testicular cancer	1.76e-05	0.000457	CcSEcCtD
Idarubicin—Flushing—Doxorubicin—testicular cancer	1.76e-05	0.000456	CcSEcCtD
Idarubicin—Angiopathy—Doxorubicin—testicular cancer	1.72e-05	0.000446	CcSEcCtD
Idarubicin—Immune system disorder—Doxorubicin—testicular cancer	1.72e-05	0.000444	CcSEcCtD
Idarubicin—Leukopenia—Methotrexate—testicular cancer	1.71e-05	0.000442	CcSEcCtD
Idarubicin—Chills—Doxorubicin—testicular cancer	1.7e-05	0.000441	CcSEcCtD
Idarubicin—Arrhythmia—Doxorubicin—testicular cancer	1.7e-05	0.000439	CcSEcCtD
Idarubicin—Nausea—Cisplatin—testicular cancer	1.69e-05	0.000436	CcSEcCtD
Idarubicin—Alopecia—Doxorubicin—testicular cancer	1.68e-05	0.000434	CcSEcCtD
Idarubicin—Convulsion—Methotrexate—testicular cancer	1.65e-05	0.000428	CcSEcCtD
Idarubicin—Vomiting—Etoposide—testicular cancer	1.65e-05	0.000428	CcSEcCtD
Idarubicin—Malnutrition—Doxorubicin—testicular cancer	1.65e-05	0.000428	CcSEcCtD
Idarubicin—Anaemia—Epirubicin—testicular cancer	1.65e-05	0.000427	CcSEcCtD
Idarubicin—Rash—Etoposide—testicular cancer	1.64e-05	0.000424	CcSEcCtD
Idarubicin—Dermatitis—Etoposide—testicular cancer	1.64e-05	0.000424	CcSEcCtD
Idarubicin—Headache—Etoposide—testicular cancer	1.63e-05	0.000422	CcSEcCtD
Idarubicin—Chest pain—Methotrexate—testicular cancer	1.63e-05	0.000421	CcSEcCtD
Idarubicin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—testicular cancer	1.61e-05	0.000418	CcSEcCtD
Idarubicin—Leukopenia—Epirubicin—testicular cancer	1.6e-05	0.000414	CcSEcCtD
Idarubicin—Anaphylactic shock—Methotrexate—testicular cancer	1.56e-05	0.000403	CcSEcCtD
Idarubicin—Convulsion—Epirubicin—testicular cancer	1.55e-05	0.000401	CcSEcCtD
Idarubicin—Infection—Methotrexate—testicular cancer	1.55e-05	0.000401	CcSEcCtD
Idarubicin—Nausea—Etoposide—testicular cancer	1.54e-05	0.0004	CcSEcCtD
Idarubicin—Anaemia—Doxorubicin—testicular cancer	1.53e-05	0.000395	CcSEcCtD
Idarubicin—Thrombocytopenia—Methotrexate—testicular cancer	1.53e-05	0.000395	CcSEcCtD
Idarubicin—Chest pain—Epirubicin—testicular cancer	1.52e-05	0.000394	CcSEcCtD
Idarubicin—Skin disorder—Methotrexate—testicular cancer	1.51e-05	0.000392	CcSEcCtD
Idarubicin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—testicular cancer	1.51e-05	0.000391	CcSEcCtD
Idarubicin—Anorexia—Methotrexate—testicular cancer	1.49e-05	0.000384	CcSEcCtD
Idarubicin—Leukopenia—Doxorubicin—testicular cancer	1.48e-05	0.000383	CcSEcCtD
Idarubicin—Anaphylactic shock—Epirubicin—testicular cancer	1.46e-05	0.000377	CcSEcCtD
Idarubicin—Infection—Epirubicin—testicular cancer	1.45e-05	0.000375	CcSEcCtD
Idarubicin—Shock—Epirubicin—testicular cancer	1.43e-05	0.000371	CcSEcCtD
Idarubicin—Convulsion—Doxorubicin—testicular cancer	1.43e-05	0.000371	CcSEcCtD
Idarubicin—Thrombocytopenia—Epirubicin—testicular cancer	1.43e-05	0.000369	CcSEcCtD
Idarubicin—Skin disorder—Epirubicin—testicular cancer	1.42e-05	0.000366	CcSEcCtD
Idarubicin—Chest pain—Doxorubicin—testicular cancer	1.41e-05	0.000364	CcSEcCtD
Idarubicin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—testicular cancer	1.4e-05	0.000362	CcSEcCtD
Idarubicin—Anorexia—Epirubicin—testicular cancer	1.39e-05	0.00036	CcSEcCtD
Idarubicin—Decreased appetite—Methotrexate—testicular cancer	1.35e-05	0.00035	CcSEcCtD
Idarubicin—Anaphylactic shock—Doxorubicin—testicular cancer	1.35e-05	0.000349	CcSEcCtD
Idarubicin—Infection—Doxorubicin—testicular cancer	1.34e-05	0.000347	CcSEcCtD
Idarubicin—Shock—Doxorubicin—testicular cancer	1.33e-05	0.000343	CcSEcCtD
Idarubicin—Thrombocytopenia—Doxorubicin—testicular cancer	1.32e-05	0.000342	CcSEcCtD
Idarubicin—Skin disorder—Doxorubicin—testicular cancer	1.31e-05	0.000339	CcSEcCtD
Idarubicin—Anorexia—Doxorubicin—testicular cancer	1.29e-05	0.000333	CcSEcCtD
Idarubicin—Gastrointestinal pain—Methotrexate—testicular cancer	1.27e-05	0.00033	CcSEcCtD
Idarubicin—Decreased appetite—Epirubicin—testicular cancer	1.27e-05	0.000328	CcSEcCtD
Idarubicin—Urticaria—Methotrexate—testicular cancer	1.24e-05	0.00032	CcSEcCtD
Idarubicin—Body temperature increased—Methotrexate—testicular cancer	1.23e-05	0.000319	CcSEcCtD
Idarubicin—Abdominal pain—Methotrexate—testicular cancer	1.23e-05	0.000319	CcSEcCtD
Idarubicin—Gastrointestinal pain—Epirubicin—testicular cancer	1.19e-05	0.000309	CcSEcCtD
Idarubicin—Decreased appetite—Doxorubicin—testicular cancer	1.17e-05	0.000303	CcSEcCtD
Idarubicin—Urticaria—Epirubicin—testicular cancer	1.16e-05	0.0003	CcSEcCtD
Idarubicin—Body temperature increased—Epirubicin—testicular cancer	1.15e-05	0.000298	CcSEcCtD
Idarubicin—Abdominal pain—Epirubicin—testicular cancer	1.15e-05	0.000298	CcSEcCtD
Idarubicin—Hypersensitivity—Methotrexate—testicular cancer	1.15e-05	0.000297	CcSEcCtD
Idarubicin—Gastrointestinal pain—Doxorubicin—testicular cancer	1.1e-05	0.000285	CcSEcCtD
Idarubicin—Hypersensitivity—Epirubicin—testicular cancer	1.07e-05	0.000278	CcSEcCtD
Idarubicin—Urticaria—Doxorubicin—testicular cancer	1.07e-05	0.000277	CcSEcCtD
Idarubicin—Body temperature increased—Doxorubicin—testicular cancer	1.07e-05	0.000276	CcSEcCtD
Idarubicin—Abdominal pain—Doxorubicin—testicular cancer	1.07e-05	0.000276	CcSEcCtD
Idarubicin—Diarrhoea—Methotrexate—testicular cancer	1.07e-05	0.000276	CcSEcCtD
Idarubicin—Diarrhoea—Epirubicin—testicular cancer	9.98e-06	0.000258	CcSEcCtD
Idarubicin—Hypersensitivity—Doxorubicin—testicular cancer	9.94e-06	0.000257	CcSEcCtD
Idarubicin—Vomiting—Methotrexate—testicular cancer	9.91e-06	0.000256	CcSEcCtD
Idarubicin—Rash—Methotrexate—testicular cancer	9.82e-06	0.000254	CcSEcCtD
Idarubicin—Dermatitis—Methotrexate—testicular cancer	9.81e-06	0.000254	CcSEcCtD
Idarubicin—Headache—Methotrexate—testicular cancer	9.76e-06	0.000253	CcSEcCtD
Idarubicin—Vomiting—Epirubicin—testicular cancer	9.27e-06	0.00024	CcSEcCtD
Idarubicin—Nausea—Methotrexate—testicular cancer	9.25e-06	0.000239	CcSEcCtD
Idarubicin—Diarrhoea—Doxorubicin—testicular cancer	9.23e-06	0.000239	CcSEcCtD
Idarubicin—Rash—Epirubicin—testicular cancer	9.19e-06	0.000238	CcSEcCtD
Idarubicin—Dermatitis—Epirubicin—testicular cancer	9.18e-06	0.000238	CcSEcCtD
Idarubicin—Headache—Epirubicin—testicular cancer	9.13e-06	0.000236	CcSEcCtD
Idarubicin—Nausea—Epirubicin—testicular cancer	8.66e-06	0.000224	CcSEcCtD
Idarubicin—Vomiting—Doxorubicin—testicular cancer	8.58e-06	0.000222	CcSEcCtD
Idarubicin—Rash—Doxorubicin—testicular cancer	8.51e-06	0.00022	CcSEcCtD
Idarubicin—Dermatitis—Doxorubicin—testicular cancer	8.5e-06	0.00022	CcSEcCtD
Idarubicin—Headache—Doxorubicin—testicular cancer	8.45e-06	0.000219	CcSEcCtD
Idarubicin—Nausea—Doxorubicin—testicular cancer	8.01e-06	0.000207	CcSEcCtD
